Note: Ingredients listed on restricted chemical lists
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
>2000
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
1-<5
General Information
Version
6
Revision date
2025-11-01
Product name
Axitinib Film Coated Tablets
Product name
Axitinib Film Coated Tablets
Identification on the label/Trade name
INLYTA
Chemical name
Not determined
1.2.1 Relevant identified uses
Pharmaceutical product used as antineoplastic
Emergency telephone
1-800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H341, H361fd, H373, H410
Hazard statements
Code
Statements
H341
Suspected of causing genetic defects
Section 2
SECTION 2: Hazards identification
OSHA Classification of the substance or mixture
2.3 Other hazards
Not applicable (HNOC) An Occupational Exposure Value has been established for one or more of the ingredients (see Section 8). Axitinib Pfizer OEL TWA-8 Hr: PBT & vPvB 10 µg/m3 The product does not contain any substance(s) classified as PBT or vPvB. Endocrine Disruptor Information This product does not contain any known or suspected endocrine disruptors. Note This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
Signal word
Warning
Hazard statements
H341 - Suspected of causing genetic defects H361fd - Suspected of damaging fertility. Suspected of damaging the unborn child H373 - May cause damage to organs through prolonged or repeated exposure: blood and blood forming organs, bone, reproductive system, gastrointestinal system. H410 - Very toxic to aquatic life with long lasting effects EUH450 - Can cause long-lasting and diffuse contamination of water resources
Precautionary statements
P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P260 - Do not breathe dust P264 - Wash skin thoroughly after handling P273 - Avoid release to the environment P280 - Wear protective gloves and protective clothing P308 + P313 - IF exposed or concerned: Get medical advice/attention P391 - Collect spillage P405 - Store locked up P501 - Dispose of contents/container in accordance with local, regional, national, and international regulations as applicable 1-<5 % of the mixture consists of ingredient(s) of unknown acute dermal toxicity. 1-<5 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (dust/mist).
2.1 Classification of the substance or mixture
GHS - Classification: Regulated according to Regulation (EC) 1272/2008 and/or other applicable regulations. Germ cell mutagenicity Category 2 - (H341) Reproductive toxicity Category 2 - (H361fd) Specific target organ toxicity (repeated exposure) Category 2 - (H373) Hazardous to the aquatic environment - acute Category 2 - (H401) Hazardous to the aquatic environment - chronic Category 1 - (H410) PMT or vPvM properties PMT - (EUH450) OSHA Classification Hazards not otherwise classified (HNOC) Not applicable Hazards classified under paragraph (d)(1)(ii) of 1910.1200 Not applicable